GNMX - Aevi Genomic Medicine, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Annual

Balance Sheet

All numbers in thousands
Breakdown
12/30/2018
12/30/2017
12/30/2016
12/30/2015
Assets
Current Assets
Cash
Cash And Cash Equivalents
12,076
33,729
39,838
53,064
Short Term Investments
-
-
-
-
Total Cash
12,076
33,729
39,838
53,064
Net Receivables
-
-
-
-
Inventory
-
-
-
-
Other Current Assets
-
0
0
0
Total Current Assets
12,246
34,622
40,173
53,811
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
192
192
1,802
1,581
Accumulated Depreciation
-172
-107
-1,425
-1,157
Net property, plant and equipment
20
85
377
424
Equity and other investments
-
-
-
-
Goodwill
-
-
-
-
Intangible Assets
-
-
-
-
Other long-term assets
11
54
11
23
Total non-current assets
31
139
388
447
Total Assets
12,277
34,761
40,561
54,258
Liabilities and stockholders' equity
Liabilities
Current Liabilities
Total Revenue
-
-
-
-
Accounts Payable
1,582
943
137
1,322
Taxes payable
-
-
-
-
Accrued liabilities
2,763
3,197
5,446
2,586
Deferred revenues
-
-
-
-
Other Current Liabilities
-
0
0
0
Total Current Liabilities
4,345
4,140
5,583
3,908
Non-current liabilities
Long Term Debt
-
-
-
-
Deferred taxes liabilities
-
-
-
-
Deferred revenues
-
-
-
-
Other long-term liabilities
-
-
-
-
Total non-current liabilities
0
0
0
0
Total Liabilities
4,345
4,140
5,583
3,908
Stockholders' Equity
Common Stock
7
6
4
4
Retained Earnings
-245,753
-214,978
-180,034
-138,130
Accumulated other comprehensive income
-
-
-
-
Total stockholders' equity
7,932
30,621
34,978
50,350
Total liabilities and stockholders' equity
12,277
34,761
40,561
54,258